Market Price

86.39 

2.78 3.3%

as of Feb 15 '19

52 Week Range:

73.16 117.79


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include creamer and chocolate systems, dairy replacers, powdered fats, nutritional beverage bases, beverages, juice and dairy bases, ice cream bases and variegates, cereals, grain based snacks, and cereal based ingredients. This segment also offers microencapsulation solutions; and human grade choline nutrients and mineral amino acid chelated products for wellness applications. Its Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The company's Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. It also sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company's Industrial Products segment provides choline chloride derivatives for hydraulic fracturing of shale natural gas wells; and methylamines, which are building blocks for the manufacture of choline products, as well as used in industrial applications. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was founded in 1967 and is headquartered in New Hampton, New York.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Equity (BVPS) 3.45
4.02
5.24
6.52
7.68
9.27
10.68
12.21
14.51
16.26
18.30
growth rate 16.5% 30.4% 24.4% 17.8% 20.7% 15.2% 14.3% 18.8% 12.1% 12.6%
Earnings BIT 24.83
28.43
40.60
50.13
56.74
59.84
65.82
86.88
93.96
90.84
99.50
growth rate 14.5% 42.8% 23.5% 13.2% 5.5% 10.0% 32.0% 8.2% -3.3% 9.5%
Avg.PE 25.71
24.88
24.10
30.12
31.65
27.62
40.32
33.20
34.43
49.54
27.59
growth rate -3.2% -3.1% 25.0% 5.1% -12.7% 46.0% -17.7% 3.7% 43.9% -44.3%
ROA 13.06
12.33
15.65
15.98
15.50
13.69
13.02
8.53
6.85
6.12
9.42
growth rate -5.6% 26.9% 2.1% -3.0% -11.7% -4.9% -34.5% -19.7% -10.7% 53.9%
ROE 19.14
18.35
20.47
19.89
18.48
15.84
14.85
14.61
13.96
11.37
15.83
growth rate -4.1% 11.6% -2.8% -7.1% -14.3% -6.3% -1.6% -4.5% -18.6% 39.2%
ROIC 15.17
15.42
19.65
18.95
18.18
15.84
14.79
8.11
8.65
7.79
11.94
growth rate 1.7% 27.4% -3.6% -4.1% -12.9% -6.6% -45.2% 6.7% -9.9% 53.3%
Cur. Ratio 1.44
2.15
2.75
4.39
5.68
7.01
7.77
1.89
2.45
1.87
1.83
growth rate 49.3% 27.9% 59.6% 29.4% 23.4% 10.8% -75.7% 29.6% -23.7% -2.1%
Quick Ratio 0.88
1.31
2.24
3.70
4.83
6.18
6.94
1.28
1.79
1.21
1.21
growth rate 48.9% 71.0% 65.2% 30.5% 28.0% 12.3% -81.6% 39.8% -32.4% 0.0%
Leverage 1.66
1.34
1.28
1.22
1.17
1.14
1.14
2.20
1.90
1.82
1.56
growth rate -19.3% -4.5% -4.7% -4.1% -2.6% 0.0% 93.0% -13.6% -4.2% -14.3%
Balance Sheet Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Acct.Receivable 30.30
29.10
32.10
34.99
42.59
40.28
71.98
60.49
83.25
91.23
growth rate -4.0% 10.3% 9.0% 21.7% -5.4% 78.7% -16.0% 37.6% 9.6%
Acct.Payable 29.53
30.23
35.75
24.35
14.71
32.51
32.56
growth rate 2.4% 18.3% -31.9% -39.6% 121.1% 0.2%
Cur.Assets 55.30
93.00
129.70
175.74
211.91
277.77
181.30
198.29
188.44
199.34
growth rate 68.2% 39.5% 35.5% 20.6% 31.1% -34.7% 9.4% -5.0% 5.8%
Total Assets 154.50
187.80
228.60
271.72
312.55
376.87
861.53
879.69
948.63
963.64
growth rate 21.6% 21.7% 18.9% 15.0% 20.6% 128.6% 2.1% 7.8% 1.6%
Cash 3.40
46.40
77.30
114.78
144.74
208.75
50.29
84.80
38.64
40.42
growth rate 1,264.7% 66.6% 48.5% 26.1% 44.2% -75.9% 68.6% -54.4% 4.6%
Inventory 16.60
14.00
15.70
18.64
20.69
24.82
49.62
46.09
57.25
60.70
growth rate -15.7% 12.1% 18.7% 11.0% 20.0% 99.9% -7.1% 24.2% 6.0%
Cur.Liabilities 25.70
33.80
29.50
30.91
30.23
35.75
95.52
81.12
101.01
108.40
growth rate 31.5% -12.7% 4.8% -2.2% 18.3% 167.2% -15.1% 24.5% 7.3%
Liabilities 40.00
40.70
41.20
39.71
39.53
45.51
469.63
415.98
427.59
346.76
growth rate 1.8% 1.2% -3.6% -0.4% 15.1% 931.8% -11.4% 2.8% -18.9%
LT Debt 17.40
6.70
0.00
3.40
0.02
3.40
3.90
297.50
260.96
245.49
183.96
growth rate -61.5% -100.0% -99.3% 14,682.6% 14.7% 7,528.2% -12.3% -5.9% -25.1%
Equity 93.08
114.50
147.10
187.50
232.01
273.01
331.36
391.90
463.71
521.03
616.88
growth rate 23.0% 28.5% 27.5% 23.7% 17.7% 21.4% 18.3% 18.3% 12.4% 18.4%
Common Shares 28.00
29.00
29.00
30.00
30.00
30.00
31.00
31.00
32.00
32.00
32.00
growth rate 3.6% 0.0% 3.5% 0.0% 0.0% 3.3% 0.0% 3.2% 0.0% 0.0%
Cash Flow Statement Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Capital Expenditures 4.87
0.00
0.00
-1.10
6.61
13.88
8.19
13.20
41.30
23.03
27.53
growth rate -100.0% 100.0% 110.0% -41.0% 61.2% 212.9% -44.2% 19.5%
Cash Dividends 1.60
2.00
2.00
3.10
4.31
11.70
0.00
7.86
9.25
10.72
12.07
growth rate 25.0% 0.0% 55.0% 39.1% 171.5% -100.0% 17.8% 15.9% 12.6%
Cash From OA 15.64
22.90
48.10
39.00
44.90
53.78
55.69
85.35
103.83
107.61
110.62
growth rate 46.4% 110.0% -18.9% 15.1% 19.8% 3.6% 53.3% 21.7% 3.7% 2.8%
FCF per Share 0.38
0.62
1.54
1.06
1.24
1.31
1.17
1.85
2.50
2.25
2.63
growth rate 63.2% 148.4% -31.2% 17.0% 5.7% -10.7% 58.1% 35.1% -10.0% 16.9%
Sale Purchase of Stock 4.34
0.21
7.16
9.11
12.61
7.19
9.73
growth rate -95.3% 3,374.3% 27.2% 38.4% -42.9% 35.3%
FCF 11.00
18.00
44.00
31.00
38.00
40.00
47.00
72.00
62.00
84.00
83.00
growth rate 63.6% 144.4% -29.6% 22.6% 5.3% 17.5% 53.2% -13.9% 35.5% -1.2%
Income Statement Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Sales 176.20
232.10
219.40
255.10
291.87
310.39
337.17
541.38
552.49
553.20
594.79
growth rate 31.7% -5.5% 16.3% 14.4% 6.4% 8.6% 60.6% 2.1% 0.1% 7.5%
Op.Income 29.30
40.70
49.80
38.77
40.01
44.87
86.88
93.96
90.84
99.50
growth rate 38.9% 22.4% -22.2% 3.2% 12.2% 93.6% 8.2% -3.3% 9.5%
IBT 28.40
40.60
50.10
56.74
59.84
65.82
77.05
87.06
82.93
88.49
growth rate 43.0% 23.4% 13.3% 5.5% 10.0% 17.1% 13.0% -4.7% 6.7%
Net Income 19.10
26.80
33.30
38.77
40.01
44.87
52.83
59.72
55.97
90.07
growth rate 40.3% 24.3% 16.4% 3.2% 12.2% 17.7% 13.1% -6.3% 60.9%
EPS 0.58
0.67
0.93
1.12
1.28
1.32
1.45
1.69
1.89
1.75
2.79
growth rate 15.5% 38.8% 20.4% 14.3% 3.1% 9.9% 16.6% 11.8% -7.4% 59.4%
Gross Profit 46.93
52.60
67.00
78.00
86.00
89.54
97.42
148.91
168.10
180.86
189.01
growth rate 12.1% 27.4% 16.4% 10.3% 4.1% 8.8% 52.9% 12.9% 7.6% 4.5%
R&D 2.90
3.30
3.20
2.89
3.42
3.62
4.81
5.99
7.33
9.31
growth rate 13.8% -3.0% -9.7% 18.4% 5.8% 32.8% 24.5% 22.3% 27.0%

Quarterly Statements

Item Name Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Earnings BIT 23.06
26.88
27.99
28.51
25.67
growth rate 16.6% 4.1% 1.9% -10.0%
Balance Sheet Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Acct.Receivable 86.72
91.23
96.00
98.60
101.21
growth rate 5.2% 5.2% 2.7% 2.7%
Acct.Payable 26.84
32.56
28.90
31.96
34.83
growth rate 21.3% -11.2% 10.6% 9.0%
Cur.Assets 193.61
199.34
211.81
241.14
225.71
growth rate 3.0% 6.3% 13.9% -6.4%
Total Assets 958.84
963.64
967.99
989.47
986.08
growth rate 0.5% 0.5% 2.2% -0.3%
Cash 34.74
40.42
42.68
62.48
42.67
growth rate 16.3% 5.6% 46.4% -31.7%
Inventory 59.62
60.70
66.27
70.07
71.78
growth rate 1.8% 9.2% 5.7% 2.4%
Cur.Liabilities 89.79
108.40
98.12
60.63
65.95
growth rate 20.7% -9.5% -38.2% 8.8%
Liabilities 372.90
346.76
328.10
326.25
300.87
growth rate -7.0% -5.4% -0.6% -7.8%
LT Debt 200.60
183.96
175.32
210.75
178.00
growth rate -8.3% -4.7% 20.2% -15.5%
Equity 585.94
616.88
639.89
663.22
685.20
growth rate 5.3% 3.7% 3.7% 3.3%
Common Shares 2.13
2.14
2.14
2.15
2.15
growth rate 0.1% 0.2% 0.4% 0.1%
Cash Flow Statement Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Capital Expenditures 6.86
9.85
3.74
3.97
5.55
growth rate 43.7% -62.1% 6.2% 40.1%
Cash Dividends 13.42
13.42
13.42
0.01
growth rate 0.0% 0.0% -100.0%
Cash From OA 33.76
31.16
25.48
21.22
32.49
growth rate -7.7% -18.2% -16.7% 53.1%
Sale Purchase of Stock 4.63
0.21
1.26
5.32
growth rate -95.5% 506.3% 321.7%
FCF 26.91
21.31
21.74
17.25
26.94
growth rate -20.8% 2.0% -20.7% 56.1%
Income Statement Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Sales 150.72
159.26
161.41
163.69
155.04
growth rate 5.7% 1.4% 1.4% -5.3%
Op.Income 23.06
26.88
27.99
28.51
25.67
growth rate 16.6% 4.1% 1.9% -10.0%
IBT 20.70
24.52
25.18
25.06
23.53
growth rate 18.5% 2.7% -0.5% -6.1%
Net Income 16.04
41.98
19.35
19.68
19.21
growth rate 161.6% -53.9% 1.7% -2.4%
EPS
growth rate
Gross Profit 46.18
51.64
51.46
53.47
48.00
growth rate 11.8% -0.4% 3.9% -10.2%
R&D 2.71
2.50
2.57
3.23
2.54
growth rate -7.9% 2.8% 25.7% -21.4%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

A (87.35)

YOY Growth Grade:

B (70.31)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 27.09 27.99 28.73
EPS / Growth 17.4% 3.09 24.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 18.2%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 17.4% 19.9% 19.9%
Future PE 27.09 31.84 31.84
Future EPS 15.28 18.87 18.87
Value Price
MOS %
102.34
18.5%
148.52
71.9%
148.52
71.9%
MOS Price 51.17 74.26 74.26
IRT 10.22 9.53 9.53

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.